Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Holdsworth

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Frontiers in Immunology|August 16, 2021
Emerging Cellular Therapies for Anti-myeloperoxidase Vasculitis and Other Autoimmune DiseasesDragana Odobasic, Stephen R Holdsworth
Nature Reviews. Nephrology|January 3, 2018
Immune-mediated kidney disease in 2017: Progress in mechanisms and therapy for immunological kidney diseaseStephen R Holdsworth, A Richard Kitching
Journal of the American Society of Nephrology : JASN|February 4, 2011
The emergence of TH17 cells as effectors of renal injuryA Richard Kitching, Stephen R Holdsworth
Springer Seminars in Immunopathology|June 5, 2003
T cells in glomerulonephritisPeter G Tipping, Stephen R Holdsworth
Journal of the American Society of Nephrology : JASN|April 21, 2006
T cells in crescentic glomerulonephritisPeter G Tipping, Stephen R Holdsworth
Seminars in Nephrology|May 30, 2007
Cytokines in glomerulonephritisPeter G Tipping, Stephen R Holdsworth
Clinical Journal of the American Society of Nephrology : CJASN|May 6, 2015
Cytokines: Names and Numbers You Should Care AboutStephen R Holdsworth, Poh-Yi Gan
Seminars in Immunopathology|October 17, 2007
Leukocytes in glomerular injuryStephen R Holdsworth, Peter G Tipping
Journal of the American Society of Nephrology : JASN|September 9, 2008
Role of mast cells in progressive renal diseasesStephen R Holdsworth, Shaun A Summers
Journal of the American Society of Nephrology : JASN|October 26, 2013
MicroRNA-155 a new therapeutic target in crescentic GNStephen R Holdsworth, Shaun A Summers
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Frontiers in Immunology|August 16, 2021
Emerging Cellular Therapies for Anti-myeloperoxidase Vasculitis and Other Autoimmune DiseasesDragana Odobasic, Stephen R Holdsworth
Nature Reviews. Nephrology|January 3, 2018
Immune-mediated kidney disease in 2017: Progress in mechanisms and therapy for immunological kidney diseaseStephen R Holdsworth, A Richard Kitching
Journal of the American Society of Nephrology : JASN|February 4, 2011
The emergence of TH17 cells as effectors of renal injuryA Richard Kitching, Stephen R Holdsworth
Springer Seminars in Immunopathology|June 5, 2003
T cells in glomerulonephritisPeter G Tipping, Stephen R Holdsworth
Journal of the American Society of Nephrology : JASN|April 21, 2006
T cells in crescentic glomerulonephritisPeter G Tipping, Stephen R Holdsworth
Seminars in Nephrology|May 30, 2007
Cytokines in glomerulonephritisPeter G Tipping, Stephen R Holdsworth
Clinical Journal of the American Society of Nephrology : CJASN|May 6, 2015
Cytokines: Names and Numbers You Should Care AboutStephen R Holdsworth, Poh-Yi Gan
Seminars in Immunopathology|October 17, 2007
Leukocytes in glomerular injuryStephen R Holdsworth, Peter G Tipping
Journal of the American Society of Nephrology : JASN|September 9, 2008
Role of mast cells in progressive renal diseasesStephen R Holdsworth, Shaun A Summers
Journal of the American Society of Nephrology : JASN|October 26, 2013
MicroRNA-155 a new therapeutic target in crescentic GNStephen R Holdsworth, Shaun A Summers
Pageof 13